RxDoctor Payments Data

Jeffry Twidwell

Urology · Edina, MNNPI 1487605887

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $4,100 of the $5,602 with a category attached, or 73.2%. Travere Therapeutics, Inc. accounts for 75.8% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2019 at $2,902 and has fallen 99.2% since, to $22 in 2022.

$5,602in general payments, 2019–2025

Across 76 payments — averaging $73.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Travere Therapeutics, Inc.$4K
  • Coloplast$253
  • Dendreon Pharmaceuticals LLC$195
  • SRS Medical Systems, Inc.$174
  • Olympus America Inc.$122
  • Antares Pharma, Inc.$120
  • plus $493 from 13 others

What the payments were for

  • Speaking & faculty fees$4,10073%
  • Food & beverage$1,35724%
  • Education$1453%

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,602 in reported general payments places this provider in the 80th percentile of 247 urology providers in Minnesota.

See all urology providers in Minnesota

Other urology in Edina

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →